Ketorolac Drug Study
Ketorolac Drug Study
Generic Name: Anti-inflammatory and Short-term management Contraindicated with CNS: Renal impairment,
Ketorolac Tromethamine analgesic activity; of pain (up to 5 days) significant renal headache, Impaired hearing,
Brand Name: inhibits prostaglandins impairment, aspirin dizziness, allergies, hepatic,
Toradol and leukotriene synthesis allergy, recent GI bleed or somnolence,
Classification: perforation Use cautiously insomnia, Skin color and lesions,
Anti-pyretic with impaired hearing; fatigue, orientation, reflexes,
NSAID allergies; hepatic dizziness peripheral sensation,
Dosage: conditions tinnitus, clotting times, CBC,
30mg (3 doses) ophthalmologic effects adventitious sounds
Route:
IVTT Be aware that patient
Frequency: may be at risk for CV
Every 6 hours events, GI bleeding,
renal toxicity, monitor
accordingly
.
Keep emergency
equipment readily
available at time of initial
dose, in case of severe
hypersensitivity reaction.